Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 1 of 6 financial statements was filed late (for 2021, 83 days late).
- 2025not filed
- 202410/10/2024
- 202313/10/2023
- 202106/10/2022
- 202015/07/2021
- 201911/09/2020
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
Industry
National Health Fund (NFZ) contracts
World Pharm Jargan-Szklorz has been an NFZ healthcare provider since 2017. In 2026 it is performing 3 contracts with a total value of USD 675.31. All its contracts were worth USD 1.30k in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Pilot programmes | śląskie | 1 | USD 675.31 |
| Provision of medical devices | śląskie | 1 | USD 0.00 |
| Other services provided in pharmacies | śląskie | 1 | USD 0.00 |
Authorized Representatives
Manner of representation
Jolanta Jargan and Katarzyna Szklorz are authorized to represent the company, acting independently.
Ownership
| Owner |
|---|
Jolanta Izabela Jarganage 63 |
Leszek Piotr Jargan |
Agata Jolanta Jargan-Barańska |
Andrzej Roman Szklorz |
Katarzyna Danuta Szklorzage 62 |
Marta Patrycja Szklorz-Papierniak |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2015-02-01.
42 2490 0005 0000 4500 7425 8942- 96 2490 0005 0000 4600 4297 3481
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,073$3,073 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 2, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,224$3,224 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 2, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,663$2,663 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Dolnośląska Grupa AptecznaS.A. | $30,168,188.68 | dgasa.pl | ||
| Management CompanyS.A. | $18,905,980.22 | managementcompany.pl | ||
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Adpharmasp. z o.o. | $4,026,799.19 | adamed.com | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| Herbarium Świętego Franciszkasp. z o.o. | $1,397,577.12 | herbarium.katowice.pl | ||
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-WarszawaS.A. | – | farmacol.com.pl |
FAQ
Last updated: 2026-03-28